Objective: This study was undertaken to evaluate the potential efficac
y of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomograp
hy (FDG PET) to detect renal tumours and to characterize indeterminate
renal cysts. Subjects and methods: Twenty-six PET scans mere performe
d in 21 patients (14 PET scans in 10 patients with malignant renal tum
ours and 12 PET scans in 11 patients with Bosniak type 3 indeterminate
renal cysts). Pathological proof was obtained in 18 of 21 patients (1
0 with solid neoplasms, eight with indeterminate cysts). Imaging was p
erformed 1 h after injection of 5-10 mCi of FDG with IV administration
of Lasix (10 mg) 20 mins after injection. Two consecutive 9.7-cm imag
e segments mere scanned to cover the entire renal areas. Results: PET
accurately depicted solid neoplasms as areas of increased uptake in ni
ne of 10 patients. Bilateral renal cell carcinomas mere missed in one
diabetic patient. All but one indeterminate renal cysts mere correctly
classified as benign (photopenic areas), but an indeterminate cyst wi
th a 4-mm papillary neoplasm was wrongly classified as benign. There m
ere no false positive PET interpretations. The mean tumour-to-kidney r
atio was 3.0 for malignant lesions.Conclusion: We conclude that FDG PE
T scanning shows promise in the evaluation of indeterminate renal cyst
s. A positive PET scan in the appropriate clinical setting obviates th
e need for cyst aspiration. A negative PET scan in conjunction with a
negative cyst aspiration offers confirmatory evidence of benignity. Ou
r preliminary results are encouraging and further work is ongoing.